Literature DB >> 4075103

GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions.

S D Skaper, R Katoh-Semba, S Varon.   

Abstract

Neurons from chick embryonic day 8 (E8) ciliary ganglia, E8 and E15 dorsal root ganglia, E8 forebrain, and from rat E18 hippocampus and striatum were cultured as monolayers in the presence or absence of GM1 ganglioside. All of the primary neurons tested were susceptible to an effect of GM1 on their neuritic outgrowth, resulting in a 2- to 3-fold stimulation over control, the recognition of which depended on selecting culture conditions appropriate to each case. The response of E8 ciliary ganglionic neurons required a serum-free medium containing ciliary neuronotrophic factor, and was most pronounced by 8 h at 3 X 10(-8) M GM1. The neuritic response by either E8 or E15 dorsal root ganglionic neurons required serum (greater than or equal to 0.3%), their appropriate neuronotrophic factor, and 100-fold higher GM1 concentrations (presumably reflecting the serum presence), with optimal response times of 12-24 h. For E8 chick forebrain and E18 rat central neurons, GM1 substantially increased the proportion of neurite-bearing neurons in a serum-free pyruvate-containing medium between 7 and 24 h, with an optimal GM1 concentration of 10(-7) M. In all cases, the response to GM1 was a time-related gain, i.e. an earlier onset of neuritic regeneration rather than permanent increase in the number of neurite-bearing neurons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075103     DOI: 10.1016/0165-3806(85)90003-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture.

Authors:  J A Rodriguez; E Piddini; T Hasegawa; T Miyagi; C G Dotti
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  Association of GPI-anchored protein TAG-1 with src-family kinase Lyn in lipid rafts of cerebellar granule cells.

Authors:  Kohji Kasahara; Kazutada Watanabe; Yasunori Kozutsumi; Atsuhiko Oohira; Tadashi Yamamoto; Yutaka Sanai
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 3.  Functional roles of glycosphingolipids in signal transduction via lipid rafts.

Authors:  K Kasahara; Y Sanai
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

4.  Preparation of (13)C-labeled ceramide by acetic acid bacteria and its incorporation in mice.

Authors:  Hiroyuki Fukami; Hideki Tachimoto; Mikiya Kishi; Takayuki Kaga; Hatsue Waki; Machiko Iwamoto; Yasukazu Tanaka
Journal:  J Lipid Res       Date:  2010-07-23       Impact factor: 5.922

5.  Stimulation of a Ca(2+)-dependent protein kinase by GM1 ganglioside in nerve growth factor-treated PC12 cells.

Authors:  B S Hilbush; J M Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 6.  Is ganglioside GM1 effective in the treatment of stroke?

Authors:  S Braune
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

7.  Monosialoganglioside GM1 blood levels in maternal and newborn umbilical cord blood at birth.

Authors:  V Zanardo; L Marchesini; G Kirschner
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

8.  Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves.

Authors:  F Di Gregorio; G Favaro; C Panozzo; M G Fiori
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 9.  Trophic factor effects on cholinergic innervation in the cerebral cortex of the adult rat brain.

Authors:  A C Cuello; D Maysinger; L Garofalo
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 10.  Ganglioside function in the development and repair of the nervous system. From basic science to clinical application.

Authors:  S D Skaper; A Leon; G Toffano
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.